Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives
Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128)
10/2008
10/30/2008US20080269108 Crystalline forms of the Di-Sodium Salt of N-(5-Chlorosalicyloyl)-8-Aminocaprylic Acid
10/30/2008US20080269105 Useful delivery of drugs can be obtained through the association of drugs with certain polymers which are referred to as CYSC polymers (crystallizable side chain polymers)
10/30/2008US20080268429 Rna - Containing Microvesicles and Methods Therefor
10/30/2008US20080268062 Stabilized particle dispersions containing surface-modified inorganic nanoparticles
10/30/2008US20080268060 passing a liquid nanoscale particle precursor material through a flow passage heated to convert the carrier into a vapor and the second component into nanoscale particles; can be incorporated in a hand held inhaler, and can be delivered to a targeted portion of the lung using the inhaler
10/30/2008US20080268056 Injectable copolymer hydrogel useful for repairing vertebral compression fractures
10/30/2008US20080268046 For phosphodiesterase inhibitor vardenafil
10/30/2008US20080268033 Biologically active methylene blue derivatives
10/30/2008US20080268027 Oral administering a drug; drying self-supporting polymer film and drug dosage
10/30/2008US20080268026 Food-induced antisecretory proteins
10/30/2008US20080268024 Compositions for Oral and/or Topical Administration
10/30/2008US20080268018 Method for forming crystallized therapeutic agents on a medical device
10/30/2008US20080268015 Methods and compositions for promoting localization of pharmaceutically active agents to bone
10/30/2008US20080268007 Beauty/medication patch
10/30/2008US20080268000 Vaccine Stabilising Formula with Live Antigens for Use in Mass Vaccination Systems
10/30/2008US20080267962 Albumin Fusion Proteins
10/30/2008US20080267919 Solid support for initiating neovascularization; blood vessels fomation; targeted neovascularization; tissue target therapy
10/30/2008US20080267893 Making up and/or caring for keratin materials, skin; hair coloring, gloss or mattness (skin makeup); monomers such as isobornyl acrylate and isobornyl methacrylate
10/30/2008US20080267885 Medicinal Compositions and Method for the Preparation Thereof
10/30/2008US20080267881 Peptide-based compounds for use as targeting vectors that bind to receptors associated with angiogenesis; may thus be used for diagnosis or therapy of, for example, malignant diseases, heart diseases, endometriosis, inflammation-related diseases, rheumatoid arthritis and Kaposi's s sarcoma
10/30/2008US20080267877 Administering carrier molecule such as albumin conjugated to mannose-6-phosphate; particularly targeting Hepatic Stellate Cells (HSC); glomeruloscherosis, interstitial fibrosis, lung fibrosis, atherosclerosis, Crohn's disease, colitis ulcerosa, glomerulonephritis and sepsis; diagnosis
10/30/2008US20080267876 Nanoparticles for Targeted Delivery of Active Agent
10/30/2008US20080267875 Androgens conjugated with mammalian proteins; diagnosis or treatment of solid cancer and hematological malignancies; exhibit synergistic action together with a cytoskeleton-acting drug; prostate cancer
10/30/2008DE102007019071A1 Stabilisierte pharmazeutische Zusammensetzung enthaltend Pregabalin A stabilized pharmaceutical composition containing pregabalin
10/30/2008CA2720269A1 Composition for enhancing bone formation
10/30/2008CA2685127A1 Glycoconjugates of rna interference agents
10/30/2008CA2684750A1 Stable recombinant adenosine deaminase
10/30/2008CA2684718A1 A foam material for medical use and method for producing same
10/30/2008CA2684544A1 Improved three-dimensional biocompatible skeleton structure containing nanoparticles
10/30/2008CA2684330A1 Optimized nucleotide sequences of vb6-845 for expression of recombinant proteins
10/30/2008CA2684328A1 Endotoxin removal
10/30/2008CA2683672A1 Ophthalmic oil-in-water emulsions containing prostaglandins
10/30/2008CA2683520A1 Vaccination regimen for b-cell vaccines
10/30/2008CA2680039A1 Pharmaceutical composition comprising edoxaban, an anticoagulant
10/30/2008CA2667637A1 Fusion proteins comprising an anti-inflammatory cytokine and an antigen for treatment of immune disorders
10/30/2008CA2659603A1 Oil producing microbes and methods of modification thereof
10/29/2008EP1985632A2 Use of VEGF2 antibodies for inhibiting photoreceptor cell proliferation
10/29/2008EP1985311A1 Agent for targeting drug to cerebral neuron
10/29/2008EP1985310A1 Solid dosage forms
10/29/2008EP1985309A1 Nanoparticle containing water-soluble non-peptidic low molecular weight substance
10/29/2008EP1985308A2 Water-soluble compositions of bioactive lipophilic compounds
10/29/2008EP1985302A1 Medicament for treatment of tumor and the use thereof
10/29/2008EP1985298A1 Ophtalmic oil-in-water emulsions containing prostaglandins
10/29/2008EP1985287A2 Pharmaceutical Excipient Complex
10/29/2008EP1985285A2 Compositions and methods for treating lymphoma
10/29/2008EP1985283A1 Gel-forming composition for medical use, devices for the application of the composition, and drug release controlling carrier
10/29/2008EP1984421A1 Polyketal polymers, and methods of making and using same
10/29/2008EP1984028A2 Aqueous pharmaceutical formulations of er selective ligands
10/29/2008EP1984027A2 Pharmaceutical composition comprising a bi-cyclic compound and method for stabilizing the bi-cyclic compound
10/29/2008EP1983983A1 Non-steroidal anti-inflammatory oral powder and liquid preparations for administration to animals
10/29/2008EP1983969A1 Low-moisture-content hard capsule and production method therefor
10/29/2008EP1750675B1 Stable oral pharmaceutical compositions of buprenorphine and salt thereof
10/29/2008EP1742985B1 Perfluoropolyether containing acrylate groups
10/29/2008EP1441764B1 Antigen arrays comprising rankl for treatment of bone disease
10/29/2008EP1317256B1 Pharmaceutical composition having modified carrier
10/29/2008EP1278868B9 Mutated form of arginine deiminase
10/29/2008EP1265608B1 Oxazolidinone tablet formulation
10/29/2008EP1216065B1 Silver-containing compositions, devices and methods for making
10/29/2008EP1156823B1 Methods for treatment of tumors and metastases using a combination of anti-angiogenic and immuno therapies
10/29/2008EP1137434B1 New cancer treatments
10/29/2008EP1071460B1 INTERNALIZING ErbB2 ANTIBODIES
10/29/2008EP1037611B1 Biodegradable mixed polymeric micelles for gene delivery
10/29/2008EP0990440B1 Pharmaceutical composition comprising 2-amino-2-[2-(4-octylphenyl)ethyl]propane-1,3-diol, a lecithin and a saccharide
10/29/2008EP0979292B1 Gene construct encoding a heterologous prodrug-activating enzyme and a cell targeting moiety
10/29/2008EP0831912B2 Improved formulation for controlled release of drugs by combining hydrophilic and hydrophobic agents
10/29/2008EP0660721B1 Monoclonal antibodies that block ligand binding to the cd22 receptor in mature b cells
10/29/2008CN101296709A 药物递送系统 Drug delivery system
10/29/2008CN101296708A 选择性vpac2受体肽激动剂 Vpac2 receptor selective agonist peptide
10/29/2008CN101296691A Transdermal drug delivery formulation
10/29/2008CN101296687A Soft agar bolus for oral drug delivery
10/29/2008CN101296686A Method of preparing an aqueous pharmaceutical composition comprising hydroxypropyl methylcellulose and pharmaceutical c0mp0siti0ns obtainable
10/29/2008CN101294158A Small numerator interference RNA for inhibiting vascellum endometrial hyperplasia
10/29/2008CN101294008A Filler, process for producing the same, and cosmetic
10/29/2008CN101293963A Amphiprotic co-continuous polymer network, preparation method and application thereof
10/29/2008CN101293933A Polyglycol modified chitosan oligosaccharide fatty acid grafting article, preparing method and application thereof
10/29/2008CN101293102A Non-virogene carrier for complexation platinum series antineoplastic medicament and preparing method thereof
10/29/2008CN101293101A Gamma-polyglutamic acid-vanadyl complexes, preparation and application thereof
10/29/2008CN101293089A Method for preparing phaescolosaxin oral administration dosage form
10/29/2008CN101293086A Medicament for easing pain and eliminating tumour and preparation method thereof
10/29/2008CN101293037A Segmented intestine targeting medicine delivery preparation of Chinese medicine and preparation method thereof
10/29/2008CN101293015A Chinese medicinal composition, preparation method and application thereof
10/29/2008CN101292994A Method for relieving or neutralizing the effect of alcohol, and products thereof
10/29/2008CN101292991A Compound gelling agent containing clindamycinum
10/29/2008CN101292985A Levofloxacin Lactate freeze-dried injection and preparation method thereof
10/29/2008CN101292982A Enoxacin freeze-dried powder needle composing prescription and preparation technique
10/29/2008CN101292981A Solid dispersion, composition of rimonabant, preparation and medicament application thereof
10/29/2008CN101292977A Pharmaceutical combination with stable strontium ranelate and its preparations
10/29/2008CN101292966A Solid dispersion of resveratrol and glycosides and preparation method thereof
10/29/2008CN101292965A Beta-carotene microcapsule and preparing method thereof
10/29/2008CN101292964A Inhalative solution formulation containing a tiotropium salt
10/29/2008CN101292962A Felodipine controlled release formulation and preparation method thereof
10/29/2008CN101292961A Method for preparing ferulic acid polylactic acid-hydroxide acetic acid copolymer microsphere
10/29/2008CN101292960A Sustained-release microsphere containing risperidone and preparation method thereof
10/29/2008CN101292959A Daidzein powder injection and preparation method thereof
10/29/2008CN101292958A Method of preparing ultra-fine danazol powder
10/29/2008CN101292957A Liposome preparation of teniposide phospholipid complexes and prepraring method thereof
10/29/2008CN101292956A Sustained-release injection containing methotrexate and its synergistic agent
10/29/2008CN101292955A Sustained-release injection containing fluorouracil synergistic agent and preparation method thereof
10/29/2008CN101292954A Anti-cancer medicament sustained-release injection
10/29/2008CN101292953A Medicament automatic release system preparation method based on conductive polymer polypyrrole
1 ... 628 629 630 631 632 633 634 635 636 637 638 639 640 641 642 643 644 645 646 647 648 ... 1712